N07AA01 - Neostigmine |
Propably not porphyrinogenic |
PNP |
Rationale
No data pointing to CYP-interaction. References consider it safe.
Chemical description
Cholinesterase inhibitor of short duration used in intestinal and bladder atonia. Hydrolyzed by cholinesterases. No data pointing to CYP-metabolism. Australian list: safe EPI-list: use South African list: use
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
References
Tradenames